Bachrach HL. 1985. Foot-and-mouth disease and its antigens. Adv Exp Med Biol 185:27–46.
Gerner W, Carr BV, Wiesmuller KH, Pfaff E, Saalmuller A, Charleston B. 2007. Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant characteristics in cattle with MHC serotype A31. Vet Res 38:565–572.
Gorlov IP, Meyer P, Liloglou T, Myles J, Boettger MB, Cassidy A, Girard L, Minna JD, Fischer R, Duffy S, Spitz MR, Haeussinger K, Kammerer S, Cantor C, Dierkesmann R, Field JK, Amos CI. 2007.
Seizure 6-like (
SEZ6L) gene and risk for lung cancer. Cancer Res 67:8406–8411.
Guzman E, Taylor G, Charleston B, Skinner MA, Ellis SA. 2008. An MHC-restricted CD8
+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol 89:667–675.
Haghparast A, Wauben MHM, Grosfeld-Stulemeyer MC, van Kooten P, Hensen EJ. 2000. Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules. Immunogenetics 51:733–742.
Janeway C, Travers P, Walport M, Shlomchik M. 2001. Immunobiology. 4 edGarland Science; New York, USA:
Male D. 2006. Mechanisms of innate imnmunity. Immunology. Male D, Brostoff J, Roth D, editors7 edElsevier Health Sciences; Philadelphia, PA, USA: p. 127–144.
Morerio C, Acquila M, Rapella A, Tassano E, Rosanda C, Panarello C. 2006. Inversion (11)(p15q22) with NUP98–DDX10 fusion gene in pediatric acute myeloid leukemia. Cancer Genet Cytogenet 171:122–125.
Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J. 2005. Genetic and epigenetic alterations of the candidate tumor-suppressor gene
MYO18B, on chromosome arm 22q, in colorectal cancer. Genes Chromosomes Cancer 43:162–171.
Nakao K, Nishino M, Takeuchi K, Iwata M, Kawano A, Arai Y, Ohki M. 2000. Fusion of the nucleoporin gene,
NUP98, and the putative RNA Helicase Gene, DZXX10, by Inversion 11 (p15q22) chromosome translocation in a patient with etoposide-related myelodysplastic syndrome. Intern Med 39:412–415.
Nishioka M, Kohno T, Takahashi M, Niki T, Yamada T, Sone S, Yokota J. 2000. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line. Oncogene 19:6251–6260.
Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S, Yokota J. 2002. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 99:12269–12274.
Nishiyama M, Arai Y, Tsunematsu Y, Kobayashi H, Asami K, Yabe M, Kato S, Oda M, Eguchi H, Ohki M, Kaneko Y. 1999. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome. Genes Chromosomes Cancer 26:215–220.
Pahl R, Schäfer H. 2010. PERMORY: an LD-exploiting permutation test algorithm for powerful genome-wide association testing. Bioinformatics 26:2093–2100.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, De Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.
Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V. 2001. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32:1–30.
Summerfield A, Guzylack-Piriou L, Harwood L, McCullough KC. 2009. Innate immune responses against foot-and-mouth disease virus: Current understanding and future directions. Vet Immunol Immunopathol 128:205–210.
Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J. 2004. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. Genes Chromosomes Cancer 40:146–151.
Yanaihara N, Nishioka M, Kohno T, Otsuka A, Okamoto A, Ochiai K, Tanaka T, Yokota J. 2004. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer. Int. J Cancer 112:150–154.
Yokota J, Kohno T. 2004. Molecular footprints of human lung cancer progression. Cancer Sci 95:197–204.
Yokota J, Nishioka M, Tani M, Kohno T. 2003. Genetic alterations responsible for metastatic phenotypes of lung cancer cells. Clin. Exp Metastasis 20:189–193.